Results of Celon’s anti-Alzheimer’s drug research on AD/PD 2013

Celon Pharma S.A. will present the results of one of its R&D projects focused on development of novel drugs for Alzheimer’s disease on The 11th International Conference on Alzheimer’s & Parkinson’s Diseases, Florence, Italy. Poster entitled: “Discovery of Novel GSK3beta Inhibitor Lead Structure Using Sequential Virtual Screening” will be displayed on 8 March 2013 in poster session #2.